Latest Apreo Health News & Updates

See the latest news and media coverage for Apreo Health. We track all announcements, press releases, and industry mentions in real time, all in one place.

Apreo Health

Clinical-stage medical device company developing emphysema treatments

apreohealth.com

Headquarters: Menlo Park, United States
Company type: Private company
Number of employees: 30–50
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Apreo Health

In short: Apreo Health raised $130M and initiated the BREATHE-3 pivotal trial to evaluate its novel airway scaffold for severe emphysema treatment.

Company announcements

September 16 Apreo Health

Apreo Health enrolls patients in BREATHE-3 trial

Evaluating the Apreo BREATHE Airway Scaffold for severe emphysema across 18 US sites.

September 8 Apreo Health

Apreo Health enrolls patients in BREATHE-3 trial

The clinical trial studies the Apreo BREATHE Airway Scaffold for severe emphysema treatment across U.S. medical centers.

May 13 Apreo Health

Apreo Health announces milestones for BREATHE Airway Scaffold technology

The BREATHE-3 clinical trial is a cornerstone, and the team will attend ATS 2026 in Orlando.

April 10 Apreo Health

Apreo Health celebrates first patient treated in BREATHE-3 Study

The study evaluates new solutions for hyperinflation from severe emphysema advancing respiratory care.

Media coverage

June 21 Applied Clinical Trials

Apreo Health Launches Pivotal BREATHE-3 Trial for Severe Emphysema | Applied Clinical Trials Online

The trial’s first patient has been treated to assess the BREATHE Airway Scaffold, which was developed to enhance breathing and daily functioning in patients with...

3 September 2025 Temple Health

Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema - Temple Health

The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.

7 August 2025 Yahoo Finance

Apreo Health raises $130m to fund emphysema implant pivotal trial

California-based startup Apreo Health has raised $130m to further the development of its implant for treating severe emphysema. The Series B round was co-led by...

20 June 2025 Yahoo Finance

Apreo Health to Present First-in-Human Data for Novel Airway Scaffold in Late-Breaking Abstract at ATS 2025

Company emerges from stealth with a new class of interventional therapy designed to expand access to treatment for severe emphysema MENLO PARK, Calif., May 13...

Never miss news about Apreo Health

Track Apreo Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.